Two Sterlington partners, Brian Slater and Brent Babcock, have been recognized as Patent Stars in the 2025 IP Stars guide, the leading directory for IP practitioners worldwide. Brian earned a Patent Star for New York and United States (National) patent practice, while Brent secured his Patent Star for United States (National). This dual honor reflects their market-leading work on complex patent matters.
With over thirty years of experience, Brian has driven favorable outcomes for life sciences companies – guiding clients through Hatch-Waxman litigations, biosimilar matters, and other high-stakes patent disputes. Leveraging his litigation experience and deep industry knowledge, Brian also counsels emerging and established life sciences companies on protecting, licensing, and monetizing their IP assets.
“Earning an IP Stars Patent Star reflects our commitment to delivering practical, high-impact results for our clients,” – Brian Slater
Brent Babcock brings more than three decades of PTAB and trial experience to post-grant challenges, inter partes reviews, and high-value patent enforcement and defense matters. Peers describe him as a strategic driver in PTAB forums, combining technical depth with a track record of decisive wins. Brent advises clients on preserving patent value across life sciences, software, and manufacturing, securing favorable post-grant outcomes and guiding cross-border enforcement strategies.
“This recognition highlights our focus on proactive patent strategies and rigorous post-grant petitioner and patent owner planning,” – Brent Babcock
IP Stars, published by Managing IP since 1990, identifies practitioners who deliver decisive results across both contentious and non-contentious IP work.
These IP Stars listings join other accolades for Brian and Brent – such as rankings in IAM Patent 1000, Managing Intellectual Property’s Patent Stars, and LMG Life Sciences – reinforcing their reputations as trusted advisors in patent litigation and post-grant proceedings.